British Columbia has adopted permanent year-round daylight saving time (DST) to improve people’s overall health, reduce disruptions for families, simplify scheduling, and provide an extra hour of evening light during the winter months. The transition to one year-round time zone began on Sunday, March 8, 2026, when clocks moved ahead […]
Industry News
Bleep LLC appoints Thomas P. Beckley to Board of Directors
Bleep LLC, maker of the Eclipse™ mask-less CPAP solution, announced technologist and electronics industry veteran Tom Beckley has joined the Company’s Board of Directors. “As a successful technology entrepreneur with extensive knowledge of AI, software and advanced electro-mechanical systems, I’m very pleased Tom has joined Bleep’s Board of Directors,” said […]
Full Commercial Launch of DeltaWave PAP Masks
REMSleep Holdings, Inc., developer of the FDA-cleared DeltaWave(TM) nasal pillow system, announced the full commercial launch of the DeltaWave product portfolio across all U.S. distribution channels, including durable medical equipment (DME) companies and institutional sales. With expanded FDA 510(k) clearance secured on January 15 and Medicare PDAC coding approved for every product […]
Techno Xperts Builds Sleep Diagnostics Distribution Platform for Latin America
After more than two decades in the global sleep medicine industry, Julia Sarmiento, former Director of Sales of the Americas for SOMNOmedics US, has launched and rapidly expanded Techno Xperts, a dedicated distribution platform serving Latin America. The company was established to increase access to advanced sleep diagnostics technologies while […]
Jamison Spencer, DDS, MS, Joins Sleep Education Partners
Jamison Spencer, DDS, MS, will serve as a contributing author for Sleepedu. His responsibilities will be primarily to author dental-sleep-related courses. Dr. Spencer has a passion for bringing practicing sleep dentists and physicians together to foster understanding and mutual respect between the two groups. His courses will discuss those relationships […]
Clear Chronic Care Expands Nationally, Enters Sleep Medicine Market
Clear Chronic Care announced continued national expansion of its Medicare-focused Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) platform, reinforcing its position as a long-term infrastructure partner to physician practices navigating value-based reimbursement. The company also announced strategic expansion into sleep medicine, where chronic oversight and adherence management are […]
ProSomnus Secures $38 Million Investment from Catalio Capital to Scale Smart Sleep Medicine
ProSomnus Sleep Technologies announced a strategic investment from Catalio Capital Management, L.P. to accelerate the global expansion of its technology-enabled sleep health platform. Under the agreement, Catalio, a premier healthcare-focused investment firm, has committed up to $38 million to advance development of next-generation remote patient monitoring (RPM) and proprietary sleep […]
Resmed Introduces Full Face Fabric Mask Designed for Comfort and Improved Sleep Health
Resmed, announced the launch of the AirTouch™ F30i Comfort mask in the United States, a new CPAP (continuous positive airway pressure) full face mask. With a soft, breathable1 fabric, the AirTouch F30i Comfort is designed to help more people start and stay on CPAP therapy. The AirTouch F30i Comfort reflects Resmed’s dedication […]
In November, the Percentage of Patients with a Telehealth Claim Increased Nationally and Regionally
The percentage of patients with a telehealth claim increased nationally and in every region in November 2025, according to FAIR Health’s Monthly Telehealth Regional Tracker. Nationally, that percentage increased from 14.5 percent in October to 15.0 percent in November, a 3.6 percent rise. The largest increase was in the Midwest, at 5.1 […]
Alkermes Completes Acquisition of Avadel, Accelerating Entry Into Sleep Medicine Market
Alkermes plc and Avadel Pharmaceuticals plc, announced Alkermes’ completion of its acquisition of Avadel, a commercial-stage biopharmaceutical company. The acquisition adds Avadel’s FDA-approved product, LUMRYZ®, to Alkermes’ commercial portfolio, and provides Alkermes with a commercial organization experienced in this disease state. This strategic move accelerates Alkermes’ entry into the sleep […]













